According to reports from ET Now, the selected stocks demonstrate consistent improvement in their Stock Reports Plus scores over the past week. The screening process covers companies listed on both BSE and NSE, utilizing quantitative filters including continuous score improvement over one week, analyst ratings of 'Buy', 'Strong Buy' or 'Hold', minimum upside potential of 16% over the next 12 months, and market capitalisation above ₹30,000 crore. The data sourced from the latest Refinitiv Stock Reports Plus dated April 18, 2026, covers stocks across sectors such as FMCG, pharmaceuticals, IT and industrials.
As reported by ET Now, the Abbott India gains were driven mainly by stronger price momentum, while Procter & Gamble Hygiene improvement was led by better relative valuation metrics. Havells India received a boost supported by stronger earnings indicators, and Dalmia Bharat saw earnings component improvements. L&T Technology Services gains were backed by a combination of better price momentum, earnings and valuation factors. The Stock Reports Plus evaluates companies across five parameters: earnings, price momentum, fundamentals, risk, and valuation, with each stock receiving a score between 1 and 10, where scores above 8 are considered positive.
According to ET Now, global cues are playing a supportive role with Iran reopening the Strait of Hormuz and US markets ending higher, leading to expectations of a strong opening for Indian equities. A sharp decline of over 12% in crude oil prices has further lifted market sentiment, something investors had been waiting for. However, uncertainty remains regarding potential geopolitical developments that could push oil prices higher. For India, natural gas supply and pricing trends will remain equally important, especially for sectors like fertilisers that directly influence food inflation.
As reported by ET Now, Monday's trading is likely to see action in sectors that were hit hardest during Gulf tensions, though valuations in several market pockets remain elevated. The article emphasizes that investors should stay cautious and focus on earnings visibility, as premium valuations can only be justified if backed by solid growth. Keeping cash in hand and closely tracking management commentary alongside Q4 results could offer valuable insights, with sectors that have recently underperformed worth watching for potential strong alpha generation.
